Image

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Join a study for preventing recurring C. diff infections.

Recruiting
12 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

VE303 for Prevention of Recurrent Clostridioides Difficile Infection aims to find out if the medicine VE303 can stop the return of a stomach infection called Clostridioides difficile, or CDI. This infection causes severe diarrhea and can be dangerous. The study will last for 8 weeks, and participants will either receive VE303 or a placebo, which looks the same but has no medicine.

People who can join the study are at least 12 years old and must have had CDI before. The study has two parts: one for people who've had CDI before, and another for people who are likely to get it again.

Participants must first finish a regular antibiotic treatment for CDI. They cannot have other types of chronic diarrhea, and can't take certain medicines just before starting the study drug.

  • The study lasts 8 weeks.
  • Participants must have had CDI before.
  • Participants can't have other chronic diarrhea types or take certain medicines.
Print
Study details
    Clostridium Difficile
    Clostridium Difficile Infections
    Clostridium Difficile Infection Recurrence
    Clostridioides Difficile Infection
    Clostridioides Difficile Infection Recurrence
    CDI
    C. Diff Infection
    Recurrent Clostridium Difficile Infection
    C.Difficile Diarrhea
    Diarrhea Infectious

NCT06237452

Vedanta Biosciences, Inc.

16 March 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.